About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNANCT06457438

Molecular Characteristics and Prevalence of Viral Hepatitis E in Human Tissue and Cell Donors

In this study, the researchers want to focus on the prevalence of anti-HEV antibodies by a new generation test, direct detection of HEV RNA, and its genotypic analysis in a group of human tissue and c...

Lead sponsor: University Hospital Ostrava•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Jiří Hynčica

CONTACT

0042059737 [email protected]

Sponsors

Lead Sponsor

University Hospital Ostrava

At the Department of Laboratory Medicine of the Faculty of Medicine of the Faculty of Medicine of the National University of Health Sciences, human tissue and cells from donors will be examined for the assessment of health eligibility and donor selection according to Decree No. 422/2008 Coll. According to the current legislation, the determination of IgG and IgM antibodies against HEV or the HEV RNA method is not part of the standard examination of human tissue and cell donors for the assessment of their health eligibility.

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•\- patients indicated for organ or cell donation

Exclusion Criteria

•\- none

Related studies

RECRUITINGPhase 2

Safety and Immunogenicity of Hecolin® in Healthy Pregnant Women

NCT05808166 · Hepatitis E Infection

Not Yet RecruitingNA

Comparative Evaluation of Oral Ursodeoxycholic Acid in Reducing Bilirubin Levels Among Patients With Acute Viral Hepatitis

NCT07525401 · Hepatitis A, Hepatitis E Virus Infection

Seroprevalence of Leptospirosis in Val Müstair, Switzerland

NCT05300425 · Leptospirosis, Hepatitis E Virus Infection, and more

COMPLETEDPhase 1

Safety Study of Hepatitis E Vaccine (HEV239)

NCT03827395 · Hepatitis E, Immunisation

Morbidity and Mortality of Hepatitis E Virus Infections in Belgium

NCT04670419 · Hepatitis E

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 13, 2024Terms

Trial snapshot

StatusRECRUITING

PhaseNA

Enrollment300

Start dateJan 2022

Last updatedJun 13, 2024

Condition

Locations shown

University Hospital Ostrava

Ostrava, Moravian-Silesian Region

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 13, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions